Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
December 14, 2023
CGD's Eeshani Kandpal speaks with the Interamerican Development Bank's Ana María Ibáñez about her recent report on women economists in Latin America, the reflection of cultural norms in education and the workplace, and the importance of role models and mentors in shaping expectations.
Blog Post
December 04, 2023
In a seminal paper, Claudia Goldin and Cecilia Rouse show that when musicians do a blind audition for symphony orchestra positions—they perform behind a curtain—women are more likely to be hired than men. But, when the curtain is up and the person hiring can see who is performing, men are more likel...
WORKING PAPERS
November 27, 2023
International financial institutions (IFIs) appear to agree that quality of policymaking sees gains from diversifying the body of policymakers, all issuing diversity, equity, and inclusion statements. But how do these institutions perform when it comes to their own staff— do they lead by example? We...
Blog Post
March 07, 2023
The EU and its member states are collectively the world’s largest aid donor, with an annual budget of over $70 billion in 2021. When it comes to global health, however, it has historically punched below its weight. In part, this is due to an internal coordination problem; health is a shared competen...
Blog Post
December 15, 2022
Most recently, the Center for Global Development hosted two conferences—the first is the Bali Care Economy Dialogue, a collaborative effort with The Asia Foundation and other partners alongside the G20, and the second our annual Birdsall House Conference on Gender Equality, this year focused on chil...
CGD NOTES
December 14, 2022
Ensuring rapid and equitable access to effective oral COVID-19 therapies is essential to reducing health disparities from COVID-19 and building a better response system for future epidemics and pandemics. A multipronged strategy for medical countermeasures must include antivirals, monoclonal antibod...
Blog Post
December 14, 2022
It’s clear that COVID-19 oral antivirals are effective, and recent deals have made them even cheaper for African countries. But should these countries be investing in these medicines? Or would spending on alternative health services be better value for money? Unfortunately, there is very little avai...
Blog Post
December 14, 2022
Four new CGD pieces, released today, examine the current state of play on COVID-19 oral antivirals. Our analyses provide a deep-dive in key cross-cutting areas—demand, voluntary licensing deals for generic supply, and deployment—and offer policy actions for 2023 and beyond.
Blog Post
December 02, 2022
An important debate is taking place in Europe right now on how to fund new antimicrobials. For months it has been speculated that the European Union may move towards implementing transferable exclusivity vouchers (TEVs). In response, 14 Member States wrote to the European Commission outlining why th...